+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharma Wholesale and Distribution Market Report 2024-2034

  • PDF Icon

    Report

  • 304 Pages
  • February 2024
  • Region: Global
  • Visiongain
  • ID: 5806177
Description Jump to:
Overall world revenue for Pharma Wholesale and Distribution Market, 2024 to 2034 in terms of value the market will surpass US$800.0 billion in 2024. The publisher predicts strong revenue growth through to 2034. This work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

The Pharma Wholesale and Distribution Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Government Initiatives for Pharmaceutical Products Driving Market Growth

The global pharmaceutical landscape is witnessing a notable surge in government initiatives aimed at fostering the development, accessibility, and affordability of pharmaceutical products. Governments worldwide are increasingly recognizing the pivotal role played by the pharmaceutical industry in public health, and they are taking proactive measures to address healthcare challenges and ensure the well-being of their populations. One prominent aspect of government initiatives involves streamlining regulatory processes to facilitate the faster approval and market entry of new pharmaceutical products. Regulatory agencies are adopting more efficient approval pathways, accelerating the evaluation of drugs, vaccines, and medical devices to address urgent health needs. Additionally, there is a growing emphasis on creating a conducive environment for research and development, with governments offering incentives, grants, and research funding to pharmaceutical companies and academic institutions. These initiatives aim to stimulate innovation, especially in areas where unmet medical needs persist.

Governments are also implementing policies to enhance the affordability and accessibility of pharmaceuticals. Price control mechanisms, generic drug promotion, and the establishment of health insurance schemes contribute to making essential medications more affordable for the general population. Public-private partnerships are increasingly being leveraged to improve healthcare infrastructure, strengthen supply chains, and expand access to pharmaceutical products, particularly in underserved regions.

Stringent Regulations Industry Growth

The pharmaceutical wholesale and distribution market face substantial challenges due to the stringent regulations imposed by governments. While regulations are crucial for ensuring the safety and quality of pharmaceutical products, their strictness can hinder the efficiency of the distribution network. Compliance with these regulations often involves significant financial investments to meet comprehensive quality control measures, implement advanced storage facilities, and ensure adherence to temperature-controlled transportation standards. The extensive documentation and reporting requirements demanded by regulatory bodies can be time-consuming and resource-intensive, impacting operational efficiency. For instance, the Food and Drug Administration (FDA) reigns supreme in regulating pharmaceutical distribution. Their Current Good Manufacturing Practice (CGMP) guidelines set stringent standards for warehousing, transportation, and record-keeping. Wholesalers and distributors need to be licensed by the FDA and comply with rigorous track-and-trace systems to prevent counterfeiting.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the Pharma Wholesale and Distribution market evolving?
  • What is driving and restraining the Pharma Wholesale and Distribution market?
  • How will each Pharma Wholesale and Distribution submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
  • How will the market shares for each Pharma Wholesale and Distribution submarket develop from 2024 to 2034?
  • What will be the main driver for the overall market from 2024 to 2034?
  • Will leading Pharma Wholesale and Distribution markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the Pharma Wholesale and Distribution projects for these leading companies?
  • How will the industry evolve during the period between 2024 and 2034? What are the implications of Pharma Wholesale and Distribution projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the Pharma Wholesale and Distribution market?
  • Where is the Pharma Wholesale and Distribution market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Pharma Wholesale and Distribution market today, and over the next 10 years:

  • The 300-page report provides 109 tables and 144 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them – NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Pharma Wholesale and Distribution market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2034, this new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Type

  • Wholesalers: Producer Wholesaler, Merchant Wholesaler, Agents and Brokers
  • Distributor: Single Party Distributor, Multi Party Distributor

Distribution Type

  • Ethical/Branded Pharma Products Distributors
  • Generic Pharma Products Distributors
  • Propaganda Cum Distribution (PCD) Franchise
  • OTC/Institutional Supply Pharma Distributors
  • Others

Product Type

  • Branded Pharmaceuticals
  • Generic Pharmaceuticals
  • Over-the-counter (OTC) Pharmaceuticals
  • Medical Devices
  • Vaccines
  • Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA
The report also includes profiles and for some of the leading companies in the Pharma Wholesale and Distribution Market, 2024 to 2034, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

  • AmerisourceBergen Corporation
  • Cardinal Health, Inc.
  • CuraScript, Inc.
  • Dakota Drug, Inc.
  • Fortissa
  • Geo-Young Co., Ltd.
  • Kingworld Medicines Group Limited
  • Mckesson Corporation
  • Medipal Holdings Corporation
  • Mutual Drug
  • Petrone Group
  • Prodigy Health LLC
  • Sinopharm Group Co. Ltd.
  • Smith Drug Co., Inc.
  • Walgreens Boots Alliance, Inc.

How will the Pharma Wholesale and Distribution Market, 2024 to 2034 report help you?

In summary, this 300+ page report provides you with the following knowledge:
  • Revenue forecasts to 2034 for Pharma Wholesale and Distribution Market, 2024 to 2034 Market, with forecasts for type, distribution type, product type, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 24 key national markets – See forecasts for the Pharma Wholesale and Distribution Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market – including company profiles for 15 of the major companies involved in the Pharma Wholesale and Distribution Market, 2024 to 2034.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. This study is for everybody needing commercial analyses for the Pharma Wholesale and Distribution Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Pharma Wholesale and Distribution Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About the Publisher
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Global Pharmaceutical Sales
3.2.1.2 Increasing Government Initiatives for Pharmaceutical Products
3.2.1.3 Rising Seaborne Pharmaceutical Transportation
3.2.1.4 Technological Advancements in Pharmaceutical Distribution
3.2.1.5 Implementation of Track and Trace Solutions
3.2.2 Market Restraining Factors
3.2.2.1 Stringent Regulations Imposed by Government
3.2.2.2 Price Pressures Likely to Challenge Market Growth
3.2.2.3 Rise in Pharmaceutical Counterfeiting
3.2.3 Market Opportunities
3.2.3.1 Specializing in Niche Drugs and Therapies
3.2.3.2 Embracing E-commerce and Digital Technologies
3.2.3.3 Focusing on Sustainability and Ethical Sourcing
3.2.3.4 Implementation of AI in Pharmaceutical Supply Chain
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat of Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Pharma Wholesale and Distribution Market Analysis by Type
4.1 Key Findings
4.2 Type Segment: Market Attractiveness Index
4.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
4.4 Wholesalers
4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.4.3 Producer Wholesaler
4.4.3.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.3.2 Market Share by Region, 2024 & 2034 (%)
4.4.4 Merchant Wholesaler
4.4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.4.2 Market Share by Region, 2024 & 2034 (%)
4.4.5 Agents and Brokers
4.4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.5.2 Market Share by Region, 2024 & 2034 (%)
4.5 Distributor
4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.5.3 Single Party Distributor
4.5.3.1 Market Size by Region, 2024-2034 (US$ Billion)
4.5.3.2 Market Share by Region, 2024 & 2034 (%)
4.5.4 Multi Party Distributor
4.5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.5.4.2 Market Share by Region, 2024 & 2034 (%)
5 Pharma Wholesale and Distribution Market Analysis by Distribution Type
5.1 Key Findings
5.2 Distribution Type Segment: Market Attractiveness Index
5.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
5.4 Ethical/Branded Pharma Products Distributors
5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Generic Pharma Products Distributors
5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Propaganda Cum Distribution (PCD) Franchise
5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
5.6.2 Market Share by Region, 2024 & 2034 (%)
5.7 OTC/Institutional Supply Pharma Distributors
5.7.1 Market Size by Region, 2024-2034 (US$ Billion)
5.7.2 Market Share by Region, 2024 & 2034 (%)
5.8 Others
5.8.1 Market Size by Region, 2024-2034 (US$ Billion)
5.8.2 Market Share by Region, 2024 & 2034 (%)
6 Pharma Wholesale and Distribution Market Analysis by Product Type
6.1 Key Findings
6.2 Product Type Segment: Market Attractiveness Index
6.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
6.4 Branded Pharmaceuticals
6.4.1 Market Size by Region, 2024-2034 (US$ Billion)
6.4.2 Market Share by Region, 2024 & 2034 (%)
6.5 Generic Pharmaceuticals
6.5.1 Market Size by Region, 2024-2034 (US$ Billion)
6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 Over-the-counter (OTC) Pharmaceuticals
6.6.1 Market Size by Region, 2024-2034 (US$ Billion)
6.6.2 Market Share by Region, 2024 & 2034 (%)
6.7 Medical Devices
6.7.1 Market Size by Region, 2024-2034 (US$ Billion)
6.7.2 Market Share by Region, 2024 & 2034 (%)
6.8 Vaccines
6.8.1 Market Size by Region, 2024-2034 (US$ Billion)
6.8.2 Market Share by Region, 2024 & 2034 (%)
6.9 Others
6.9.1 Market Size by Region, 2024-2034 (US$ Billion)
6.9.2 Market Share by Region, 2024 & 2034 (%)
7 Pharma Wholesale and Distribution Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast
8 North America Pharma Wholesale and Distribution Market Analysis
8.1 Key Findings
8.2 North America Pharma Wholesale and Distribution Market Attractiveness Index
8.3 North America Pharma Wholesale and Distribution Market by Country, 2024, 2029 & 2034 (US$ Billion)
8.4 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
8.5 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
8.6 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
8.7 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
8.8 U.S. Pharma Wholesale and Distribution Market Analysis
8.9 Canada Pharma Wholesale and Distribution Market Analysis
9 Europe Pharma Wholesale and Distribution Market Analysis
9.1 Key Findings
9.2 Europe Pharma Wholesale and Distribution Market Attractiveness Index
9.3 Europe Pharma Wholesale and Distribution Market by Country, 2024, 2029 & 2034 (US$ Billion)
9.4 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
9.5 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
9.6 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
9.7 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
9.8 Germany Pharma Wholesale and Distribution Market Analysis
9.9 France Pharma Wholesale and Distribution Market Analysis
9.10 UK Pharma Wholesale and Distribution Market Analysis
9.11 Italy Pharma Wholesale and Distribution Market Analysis
9.12 Spain Pharma Wholesale and Distribution Market Analysis
9.13 Russia Pharma Wholesale and Distribution Market Analysis
9.14 Rest of Europe Pharma Wholesale and Distribution Market Analysis
10 Asia Pacific Pharma Wholesale and Distribution Market Analysis
10.1 Key Findings
10.2 Asia Pacific Pharma Wholesale and Distribution Market Attractiveness Index
10.3 Asia Pacific Pharma Wholesale and Distribution Market by Country, 2024, 2029 & 2034 (US$ Billion)
10.4 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
10.5 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
10.6 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
10.7 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
10.8 Japan Pharma Wholesale and Distribution Market Analysis
10.9 China Pharma Wholesale and Distribution Market Analysis
10.10 India Pharma Wholesale and Distribution Market Analysis
10.11 Australia Pharma Wholesale and Distribution Market Analysis
10.12 South Korea Pharma Wholesale and Distribution Market Analysis
10.13 Singapore Pharma Wholesale and Distribution Market Analysis
10.14 Rest of Asia Pacific Pharma Wholesale and Distribution Market Analysis
11 Latin America Pharma Wholesale and Distribution Market Analysis
11.1 Key Findings
11.2 Latin America Pharma Wholesale and Distribution Market Attractiveness Index
11.3 Latin America Pharma Wholesale and Distribution Market by Country, 2024, 2029 & 2034 (US$ Billion)
11.4 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
11.5 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
11.6 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
11.7 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
11.8 Brazil Pharma Wholesale and Distribution Market Analysis
11.9 Mexico Pharma Wholesale and Distribution Market Analysis
11.10 Argentina Pharma Wholesale and Distribution Market Analysis
11.11 Colombia Pharma Wholesale and Distribution Market Analysis
11.12 Rest of Latin America Pharma Wholesale and Distribution Market Analysis
12 MEA Pharma Wholesale and Distribution Market Analysis
12.1 Key Findings
12.2 MEA Pharma Wholesale and Distribution Market Attractiveness Index
12.3 MEA Pharma Wholesale and Distribution Market by Country, 2024, 2029 & 2034 (US$ Billion)
12.4 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
12.5 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
12.6 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
12.7 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
12.8 GCC Pharma Wholesale and Distribution Market Analysis
12.9 South Africa Pharma Wholesale and Distribution Market Analysis
12.10 Rest of MEA Pharma Wholesale and Distribution Market Analysis
13 Company Profiles
13.1 Competitive Landscape, 2022
13.2 Strategic Outlook
13.3 AmerisourceBergen Corporation
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2017-2022
13.3.3.2 Regional Market Shares, 2022
13.3.4 Service Benchmarking
13.3.5 Strategic Outlook
13.4 Cardinal Health, Inc.
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2017-2022
13.4.3.2 Regional Market Shares, 2022
13.4.4 Service Benchmarking
13.4.5 Strategic Outlook
13.5 CuraScript, Inc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Service Benchmarking
13.6 Dakota Drug, Inc.
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Service Benchmarking
13.7 Fortissa
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Service Benchmarking
13.8 Geo-Young Co., Ltd.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Service Benchmarking
13.9 Kingworld Medicines Group Limited
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Service Benchmarking
13.10 Mckesson Corporation
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2017-2022
13.10.3.2 Regional Market Shares, 2022
13.10.4 Service Benchmarking
13.10.5 Strategic Outlook
13.11 Medipal Holdings Corporation
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis
13.11.3.1 Net Revenue, 2017-2022
13.11.4 Service Benchmarking
13.11.5 Strategic Outlook
13.12 Mutual Drug
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Service Benchmarking
13.13 Petrone Group
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Service Benchmarking
13.13.4 Strategic Outlook
13.14 Prodigy Health LLC
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Service Benchmarking
13.15 Sinopharm Group Co. Ltd.
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Financial Analysis
13.15.3.1 Net Revenue, 2017-2022
13.15.4 Service Benchmarking
13.15.5 Strategic Outlook
13.16 Smith Drug Co., Inc.
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Service Benchmarking
13.17 Walgreens Boots Alliance, Inc.
13.17.1 Company Snapshot
13.17.2 Company Overview
13.17.3 Financial Analysis
13.17.3.1 Net Revenue, 2017-2022
13.17.4 Service Benchmarking
13.17.5 Strategic Outlook
14 Conclusion and Recommendations
14.1 Concluding Remarks from the Publisher
14.2 Recommendations for Market Players
List of Tables
Table 1 Pharma Wholesale and Distribution Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 Pharma Wholesale and Distribution Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Pharma Wholesale and Distribution Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Pharma Wholesale and Distribution Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Pharma Wholesale and Distribution Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 7 Wholesalers Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 8 Producer Wholesaler Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 9 Merchant Wholesaler Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 10 Agents and Brokers Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 11 Distributor Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 12 Single Party Distributor Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 13 Multi Party Distributor Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 14 Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 15 Ethical/Branded Pharma Products Distributors Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 16 Generic Pharma Products Distributors Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 17 Propaganda Cum Distribution (PCD) Franchise Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 18 OTC/Institutional Supply Pharma Distributors Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 19 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 20 Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 21 Branded Pharmaceuticals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 22 Generic Pharmaceuticals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 23 Over-the-counter (OTC) Pharmaceuticals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 24 Medical Devices Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 25 Vaccines Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 26 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 27 Pharma Wholesale and Distribution Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 28 North America Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 29 North America Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 30 North America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 31 North America Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 32 U.S. Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 33 Canada Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 34 Europe Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 35 Europe Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 36 Europe Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 37 Europe Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 38 Germany Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 39 France Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 40 UK Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 41 Italy Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 42 Spain Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 43 Russia Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 44 Rest of Europe Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 45 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 46 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 47 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 48 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 49 Japan Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 50 China Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 51 India Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 52 Australia Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 53 South Korea Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 54 Singapore Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 55 Rest of Asia Pacific Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 56 Latin America Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 57 Latin America Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 58 Latin America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 59 Latin America Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 60 Brazil Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 61 Mexico Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 62 Argentina Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 63 Colombia Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 64 Rest of Latin America Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 65 MEA Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 66 MEA Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 67 MEA Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 68 MEA Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 69 GCC Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 70 South Africa Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 71 Rest of MEA Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 72 Strategic Outlook
Table 73 AmerisourceBergen Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 AmerisourceBergen Corporation: Service Benchmarking
Table 75 AmerisourceBergen Corporation: Strategic Outlook
Table 76 Cardinal Health, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Cardinal Health, Inc.: Service Benchmarking
Table 78 Cardinal Health, Inc.: Strategic Outlook
Table 79 CuraScript, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 CuraScript, Inc.: Service Benchmarking
Table 81 Dakota Drug, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 Dakota Drug, Inc.: Service Benchmarking
Table 83 Fortissa: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Fortissa: Service Benchmarking
Table 85 Geo-Young Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Geo-Young Co., Ltd.: Service Benchmarking
Table 87 Kingworld Medicines Group Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Kingworld Medicines Group Limited: Service Benchmarking
Table 89 Mckesson Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Mckesson Corporation: Service Benchmarking
Table 91 Mckesson Corporation: Strategic Outlook
Table 92 Medipal Holdings Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Medipal Holdings Corporation: Service Benchmarking
Table 94 Medipal Holdings Corporation: Strategic Outlook
Table 95 Mutual Drug: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Mutual Drug: Service Benchmarking
Table 97 Petrone Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Petrone Group: Service Benchmarking
Table 99 Petrone Group: Strategic Outlook
Table 100 Prodigy Health LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Prodigy Health LLC: Service Benchmarking
Table 102 Sinopharm Group Co. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Sinopharm Group Co. Ltd.: Service Benchmarking
Table 104 Sinopharm Group Co. Ltd.: Strategic Outlook
Table 105 Smith Drug Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Smith Drug Co., Inc.: Service Benchmarking
Table 107 Walgreens Boots Alliance, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Walgreens Boots Alliance, Inc.: Service Benchmarking
Table 109 Walgreens Boots Alliance, Inc.: Strategic Outlook
List of Figures
Figure 1 Pharma Wholesale and Distribution Market Segmentation
Figure 2 Pharma Wholesale and Distribution Market by Type: Market Attractiveness Index
Figure 3 Pharma Wholesale and Distribution Market by Distribution Type: Market Attractiveness Index
Figure 4 Pharma Wholesale and Distribution Market by Product Type: Market Attractiveness Index
Figure 5 Pharma Wholesale and Distribution Market Attractiveness Index by Region
Figure 6 Pharma Wholesale and Distribution Market: Market Dynamics
Figure 7 Pharma Wholesale and Distribution Market by Region, 2024-2034 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 8 Pharma Wholesale and Distribution Market by Region, 2024-2034 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 9 Pharma Wholesale and Distribution Market by Region, 2024-2034 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 10 Pharma Wholesale and Distribution Market by Region, 2024-2034 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 11 Pharma Wholesale and Distribution Market: Porter’s Five Forces Analysis
Figure 12 Pharma Wholesale and Distribution Market: PEST Analysis
Figure 13 Pharma Wholesale and Distribution Market by Type: Market Attractiveness Index
Figure 14 Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 15 Pharma Wholesale and Distribution Market Share Forecast by Type, 2023, 2028, 2033 (%)
Figure 16 Wholesalers Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 17 Wholesalers Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 18 Producer Wholesaler Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 19 Producer Wholesaler Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 20 Merchant Wholesaler Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 21 Merchant Wholesaler Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 22 Agents and Brokers Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 23 Agents and Brokers Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 24 Distributor Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 25 Distributor Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 26 Single Party Distributor Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 27 Single Party Distributor Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 28 Multi Party Distributor Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 29 Multi Party Distributor Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 30 Pharma Wholesale and Distribution Market by Distribution Type: Market Attractiveness Index
Figure 31 Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR %)
Figure 32 Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2024, 2029, 2034 (%)
Figure 33 Ethical/Branded Pharma Products Distributors Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 34 Ethical/Branded Pharma Products Distributors Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 35 Generic Pharma Products Distributors Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 36 Generic Pharma Products Distributors Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 37 Propaganda Cum Distribution (PCD) Franchise Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 38 Propaganda Cum Distribution (PCD) Franchise Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 39 OTC/Institutional Supply Pharma Distributors Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 40 OTC/Institutional Supply Pharma Distributors Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 41 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 42 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 43 Pharma Wholesale and Distribution Market by Product Type: Market Attractiveness Index
Figure 44 Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 45 Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2024, 2029, 2034 (%)
Figure 46 Branded Pharmaceuticals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 47 Branded Pharmaceuticals Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 48 Generic Pharmaceuticals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 49 Generic Pharmaceuticals Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 50 Over-the-counter (OTC) Pharmaceuticals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 51 Over-the-counter (OTC) Pharmaceuticals Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 52 Medical Devices Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 53 Medical Devices Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 54 Vaccines Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 55 Vaccines Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 56 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 57 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 58 Pharma Wholesale and Distribution Market Forecast by Region 2024 and 2034 (Revenue, CAGR%)
Figure 59 Pharma Wholesale and Distribution Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 60 Pharma Wholesale and Distribution Market by Region, 2024-2034 (US$ Billion, AGR %)
Figure 61 North America Pharma Wholesale and Distribution Market Attractiveness Index
Figure 62 North America Pharma Wholesale and Distribution Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 63 North America Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 64 North America Pharma Wholesale and Distribution Market Share Forecast by Country, 2024 & 2034 (%)
Figure 65 North America Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 66 North America Pharma Wholesale and Distribution Market Share Forecast by Type, 2024 & 2034 (%)
Figure 67 North America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR %)
Figure 68 North America Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2024 & 2034 (%)
Figure 69 North America Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 70 North America Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 71 U.S. Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 72 Canada Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 73 Europe Pharma Wholesale and Distribution Market Attractiveness Index
Figure 74 Europe Pharma Wholesale and Distribution Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 75 Europe Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 76 Europe Pharma Wholesale and Distribution Market Share Forecast by Country, 2024 & 2034 (%)
Figure 77 Europe Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 78 Europe Pharma Wholesale and Distribution Market Share Forecast by Type, 2024 & 2034 (%)
Figure 79 Europe Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR %)
Figure 80 Europe Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2024 & 2034 (%)
Figure 81 Europe Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR.%)
Figure 82 Europe Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 83 Germany Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 84 France Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 85 UK Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 86 Italy Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 87 Spain Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 88 Russia Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 89 Rest of Europe Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 90 Asia Pacific Pharma Wholesale and Distribution Market Attractiveness Index
Figure 91 Asia Pacific Pharma Wholesale and Distribution Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 92 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 93 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Country, 2024 & 2034 (%)
Figure 94 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 95 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Type, 2024 & 2034 (%)
Figure 96 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR %)
Figure 97 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2024 & 2034 (%)
Figure 98 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 99 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 100 Japan Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 101 China Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 102 India Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 103 Australia Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 104 South Korea Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 105 Singapore Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 106 Rest of Asia Pacific Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 107 Latin America Pharma Wholesale and Distribution Market Attractiveness Index
Figure 108 Latin America Pharma Wholesale and Distribution Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 109 Latin America Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 110 Latin America Pharma Wholesale and Distribution Market Share Forecast by Country, 2024 & 2034 (%)
Figure 111 Latin America Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 112 Latin America Pharma Wholesale and Distribution Market Share Forecast by Type, 2024 & 2034 (%)
Figure 113 Latin America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR %)
Figure 114 Latin America Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2024 & 2034 (%)
Figure 115 Latin America Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 116 Latin America Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 117 Brazil Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 118 Mexico Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 119 Argentina Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 120 Colombia Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 121 Rest of Latin America Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 122 MEA Pharma Wholesale and Distribution Market Attractiveness Index
Figure 123 MEA Pharma Wholesale and Distribution Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 124 MEA Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 125 MEA Pharma Wholesale and Distribution Market Share Forecast by Country, 2024 & 2034 (%)
Figure 126 MEA Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 127 MEA Pharma Wholesale and Distribution Market Share Forecast by Type, 2024 & 2034 (%)
Figure 128 MEA Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR %)
Figure 129 MEA Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2024 & 2034 (%)
Figure 130 MEA Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 131 MEA Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 132 GCC Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 133 South Africa Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 134 Rest of MEA Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 135 Pharma Wholesale and Distribution Market: Company Share/Ranking, 2022
Figure 136 AmerisourceBergen Corporation: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 137 AmerisourceBergen Corporation: Regional Market Shares, 2022
Figure 138 Cardinal Health, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 139 Cardinal Health, Inc.: Regional Market Shares, 2022
Figure 140 Mckesson Corporation: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 141 Mckesson Corporation: Regional Market Shares, 2022
Figure 142 Medipal Holdings Corporation: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 143 Sinopharm Group Co. Ltd.: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 144 Walgreens Boots Alliance, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR %)

Companies Mentioned

  • AmerisourceBergen Corporation
  • Cardinal Health, Inc.
  • CuraScript, Inc.
  • Dakota Drug, Inc.
  • Fortissa
  • Geo-Young Co., Ltd.
  • Kingworld Medicines Group Limited
  • Mckesson Corporation
  • Medipal Holdings Corporation
  • Mutual Drug
  • Petrone Group
  • Prodigy Health LLC
  • Sinopharm Group Co. Ltd.
  • Smith Drug Co., Inc.
  • Walgreens Boots Alliance, Inc.
  • AAH Pharmaceuticals
  • Abbott India
  • Al-Dawaa Pharmacies
  • Alfresa Corporation
  • Alibaba Health
  • Alliance Healthcare
  • AstraZeneca
  • China Resources Pharmaceutical Group
  • Cipla
  • DHL Supply Chain
  • Giuliani Pharma
  • Korea United Pharm Inc.
  • Phoenix Group
  • Protek Group
  • Sanofi
  • Shanghai Pharmaceutical Group
  • Sumitomo Dainippon Pharma
  • Zuellig Pharma
  • Association of Pharmaceutical Manufacturers and Wholesalers (AMHW)
  • Central Drugs Standard Control Organization (CDSCO)
  • European Medicines Agency
  • Healthcare Distribution Alliance (HDA)
  • Italian Medicines Agency
  • Medicines and Healthcare products Regulatory Agency (MHRA)
  • National Medical Products Administration (NMPA)
  • National Pharmaceutical Pricing Observatory
  • National Reimbursement Drug List (NRDL)
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • Spanish Agency of Medicines and Medical Devices

Related Topics

Related Reports

Allergic Rhinitis Drugs Market Report 2024-2034 - Product Image

Allergic Rhinitis Drugs Market Report 2024-2034

  • Report
  • 322 Pages
  • Global
From
Clinical Trial Supply and Logistics Market for Pharma 2023-2033 - Product Image

Clinical Trial Supply and Logistics Market for Pharma 2023-2033

  • Report
  • 258 Pages
  • Global
From
Global Omega 3 Prescription Drugs Market Analysis & Forecast 2024-2034: Market By Drug; By Application; By Distribution Channel; and By Region - Product Image

Global Omega 3 Prescription Drugs Market Analysis & Forecast 2024-2034: Market By Drug; By Application; By Distribution Channel; and By Region

  • Report
  • 145 Pages
  • Global
From
Global Morphine Drugs Market - Product Image

Global Morphine Drugs Market

  • Report
  • 200 Pages
  • Global
From
Factor D Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 - Product Image

Factor D Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.